Influenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment
Authors:
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 180, 104828
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
- Japan Society for the Promotion of Science
This publication has 13 references indexed in Scilit:
- Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019Emerging Infectious Diseases, 2019
- A humanized MDCK cell line for the efficient isolation and propagation of human influenza virusesNature Microbiology, 2019
- Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019Eurosurveillance, 2019
- Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasonsEurosurveillance, 2019
- Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018Eurosurveillance, 2019
- Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir MarboxilFrontiers in Microbiology, 2018
- In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunitAntiviral Research, 2018
- Baloxavir Marboxil for Uncomplicated Influenza in Adults and AdolescentsNew England Journal of Medicine, 2018
- Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxilScientific Reports, 2018
- Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus InfectionsThe Journal of Infectious Diseases, 2010